MEM 16.7% 0.5¢ memphasys limited.

I think BD1 has sucked a lot of the momentum from biotech...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 64 Posts.
    lightbulb Created with Sketch. 20
    I think BD1 has sucked a lot of the momentum from biotech stocks. But between BD1 and BIT, I think MEM has the most promise. We're literally on stage 4 clinical trials, and given the people that the organization has chosen for stage 4 trials, I'm pretty sure their confident that there's going to be positive feedback. worth at least 20 cents a share. I guess MEM isn't as sexy as the other biotech's, being to do with isolating sperm cells. Which is ironic.
 
watchlist Created with Sketch. Add MEM (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $13.00M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $19.10K 3.821M

Buyers (Bids)

No. Vol. Price($)
11 4204169 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 5374720 3
View Market Depth
Last trade - 15.56pm 07/11/2024 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.